- Home
- SOLV vs BXP Comparison
SOLV vs BXP Comparison
Compare SOLV & BXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOLV
- BXP
- Stock Information
- Founded
- SOLV 2023
- BXP 1970
- Country
- SOLV United States
- BXP United States
- Employees
- SOLV N/A
- BXP N/A
- Industry
- SOLV
- BXP Real Estate Investment Trusts
- Sector
- SOLV
- BXP Real Estate
- Exchange
- SOLV NYSE
- BXP Nasdaq
- Market Cap
- SOLV 12.7B
- BXP 10.4B
- IPO Year
- SOLV N/A
- BXP 1997
- Fundamental
- Price
- SOLV $75.55
- BXP $66.84
- Analyst Decision
- SOLV Hold
- BXP Buy
- Analyst Count
- SOLV 10
- BXP 14
- Target Price
- SOLV $80.29
- BXP $79.57
- AVG Volume (30 Days)
- SOLV 786.6K
- BXP 2.0M
- Earning Date
- SOLV 08-07-2025
- BXP 07-29-2025
- Dividend Yield
- SOLV N/A
- BXP 5.71%
- EPS Growth
- SOLV N/A
- BXP N/A
- EPS
- SOLV 2.18
- BXP N/A
- Revenue
- SOLV $8,308,000,000.00
- BXP $3,397,133,000.00
- Revenue This Year
- SOLV $4.11
- BXP $2.42
- Revenue Next Year
- SOLV $0.14
- BXP $2.80
- P/E Ratio
- SOLV $34.81
- BXP N/A
- Revenue Growth
- SOLV 1.29
- BXP 3.47
- 52 Week Low
- SOLV $47.16
- BXP $54.22
- 52 Week High
- SOLV $85.92
- BXP $90.11
- Technical
- Relative Strength Index (RSI)
- SOLV N/A
- BXP 43.18
- Support Level
- SOLV N/A
- BXP $66.57
- Resistance Level
- SOLV N/A
- BXP $72.69
- Average True Range (ATR)
- SOLV 0.00
- BXP 1.88
- MACD
- SOLV 0.00
- BXP -0.74
- Stochastic Oscillator
- SOLV 0.00
- BXP 15.09
About SOLV SOLVENTUM CORP
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
About BXP Boston Properties Inc.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.